Key statistics
On Wednesday, Edwards Lifesciences Corp (EW:NYQ) closed at 79.33, -9.74% below its 52-week high of 87.89, set on Dec 05, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 78.61 |
|---|---|
| High | 79.91 |
| Low | 74.66 |
| Bid | -- |
| Offer | -- |
| Previous close | 77.05 |
| Average volume | 5.89m |
|---|---|
| Shares outstanding | 580.30m |
| Free float | 574.93m |
| P/E (TTM) | 43.92 |
| Market cap | 46.04bn USD |
| EPS (TTM) | 1.81 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
More ▼
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
- Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
- Edwards Comments on JenaValve Acquisition
- FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
- Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
More ▼
